ENTITY
SMARTSCORE: 3.2/5
Shanghai Henlius Biotech

Shanghai Henlius Biotech (2696 HK)

277
Analysis
Health CareChina
Shanghai Henlius Biotech, Inc develops and produces drugs. The Company develops and produces monoclonal antibody biosimilar drugs, bio betters, novel monoclonal antibodys, and other drugs. Shanghai Henlius Biotech throughout China.
more
News Icon
No news found
We’ll display news we find for Shanghai Henlius Biotech here
x